Rhythm Biosciences Ltd. (AU:RHY)
ASX:RHY
Total Valuation
Rhythm Biosciences Ltd. has a market cap or net worth of AU$65.59M. The enterprise value is AU$61.44M.
Market CapAU$65.59M
Enterprise ValueAU$61.44M
Share Statistics
Rhythm Biosciences Ltd. has 340,368,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding340,368,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rhythm Biosciences Ltd.’s return on equity (ROE) is -5.80 and return on invested capital (ROIC) is -198.68%.
Return on Equity (ROE)-5.80
Return on Assets (ROA)-1.35
Return on Invested Capital (ROIC)-198.68%
Return on Capital Employed (ROCE)-5.25
Revenue Per Employee138.78K
Profits Per Employee-166.49K
Employee Count23
Asset Turnover1.13
Inventory Turnover3.02
Valuation Ratios
The current PE Ratio of Rhythm Biosciences Ltd. is ―. Rhythm Biosciences Ltd.’s PEG ratio is 0.07.
PE Ratio―
PS Ratio4.56
PB Ratio22.03
Price to Fair Value22.03
Price to FCF-4.94
Price to Operating Cash Flow-9.10
PEG Ratio0.07
Income Statement
In the last 12 months, Rhythm Biosciences Ltd. had revenue of 3.19M and earned -3.83M in profits. Earnings per share was -0.01.
Revenue3.19M
Gross Profit2.97M
Operating Income-3.53M
Pretax Income-3.83M
Net Income-3.83M
EBITDA-3.53M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -6.11M and capital expenditures -24.23K, giving a free cash flow of -6.14M billion.
Operating Cash Flow-6.11M
Free Cash Flow-6.14M
Free Cash Flow per Share-0.02
Dividends & Yields
Rhythm Biosciences Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.94
52-Week Price Change143.59%
50-Day Moving Average0.20
200-Day Moving Average0.12
Relative Strength Index (RSI)48.07
Average Volume (3m)462.98K
Important Dates
Rhythm Biosciences Ltd. upcoming earnings date is Aug 27, 2026, TBA (Confirmed).
Last Earnings DateFeb 18, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
Rhythm Biosciences Ltd. as a current ratio of 0.84, with Debt / Equity ratio of 12.24%
Current Ratio0.84
Quick Ratio0.80
Debt to Market Cap0.07
Net Debt to EBITDA0.08
Interest Coverage Ratio-52.95
Taxes
In the past 12 months, Rhythm Biosciences Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Rhythm Biosciences Ltd. EV to EBITDA ratio is -4.03, with an EV/FCF ratio of -4.84.
EV to Sales4.46
EV to EBITDA-4.03
EV to Free Cash Flow-4.84
EV to Operating Cash Flow-4.88
Balance Sheet
Rhythm Biosciences Ltd. has AU$1.73M in cash and marketable securities with AU$262.44K in debt, giving a net cash position of AU$1.47M billion.
Cash & Marketable SecuritiesAU$1.73M
Total DebtAU$262.44K
Net CashAU$1.47M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share>-AU$0.01
Margins
Gross margin is -6405.08%, with operating margin of -110.68%, and net profit margin of -119.97%.
Gross Margin-6405.08%
Operating Margin-110.68%
Pretax Margin-119.97%
Net Profit Margin-119.97%
EBITDA Margin-110.68%
EBIT Margin-116.85%
Analyst Forecast
The average price target for Rhythm Biosciences Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast56.42%